Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency Ablation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT04209959
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Registry
-
NCT04209959
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04209959. Randomized; single masking; primary purpose treatment. Start 2019-01-01 (actual); primary completion 2020-01-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency Ablation
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- nifekalant
- Lead sponsor
- Second Affiliated Hospital of Nanchang University
Record details
- Record id
cardio:ct-nct04209959- Content hash
b720d2f14ca570de13f697e1ab7aefd4216bb0d06e4944bba947f35733c2e7f7